Growth, Development in Pediatric Liver Transplant RecipientsNCT07574398
A Survey on Growth Development in Children After Liver Transplantation
An observational study of Growth, Development in Pediatric Liver Transplant Recipients, run by RenJi Hospital at 1 site in China.
Trial summary
A single-center, large-sample, long-term longitudinal study was conducted to explore the trends and characteristics of changes in growth, development in pediatric liver transplant recipients, with the aim of guiding the development of intervention strategies and optimizing follow-up protocols. Read more about this study
- Who is it for?
- Ages Up to 1 year
- Conditions the study is for
- Growth, Development in Pediatric Liver Transplant Recipients
- How many people
- 275 participants
- Where
- 1 siteChina
- Study dates
- 20 Nov 2024to 31 Dec 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 1 year
- All sexes
- Child
Study population: Children who underwent liver transplantation.
Who may be able to join
- Children with end-stage liver disease of various etiologies requiring liver transplantation.
- Approved by the ethics committee, and written informed consent has been obtained from the parents/legal guardians.
- Age ≤ 1 year (infancy).
Who cannot join
- Age older than 1 year old.
- Accept liver kidney combined transplantation surgery or second liver transplantation surgery.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site, 1 recruiting
- Recruiting
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality
Yefeng Lu, +86 135 6415 8, yefenglutwo@126.com
About this study
Official title: Longitudinal Study on Physical Growth in Children After Liver Transplantation
A single-center, large-sample, long-term longitudinal study was conducted to explore the trends and characteristics of changes in growth, development in pediatric liver transplant recipients, with the aim of guiding the development of intervention strategies and optimizing follow-up protocols.
What is being measured
The primary outcome is the main question the study is designed to answer.
BMI Z-score
Measured: 1 week before liver transplantation; 1 month, 3 months, 6 months, 1 year, 3 years, and 5 years after liver transplantation
Secondary outcomes (1)
Overall survival
Measured: 1 week before liver transplantation; 1 month, 3 months, 6 months, 1 year, 3 years, and 5 years after liver transplantation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 May 2026
- Study start20 Nov 2024
- Primary completion31 Dec 2029 (estimated)
- Study completion31 Dec 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Growth, Development in Pediatric Liver Transplant RecipientsStudies of the same condition, open and under way.
- More trials run by RenJi HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 275 participants (estimated)
Sponsor and investigators
- Lead sponsor
- RenJi Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07574398
- Sponsor's protocol ID
- IIT-2024-0335
- Status last verified
- May 2026
- First submitted
- 27 Apr 2026
- Last updated
- 7 May 2026
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Longitudinal Study on Physical Growth in Children After Liver Transplantation
- ClinicalTrials.gov ID
- NCT07574398
- Acronym / sponsor ID
- IIT-2024-0335
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 275 participants (estimated)
- Lead sponsor
- RenJi HospitalUniversity, hospital or other
- Study start
- 20 Nov 2024 (actual)
- Primary completion
- 31 Dec 2029 (estimated)
- Study completion
- 31 Dec 2029 (estimated)
- First posted
- 7 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A single-center, large-sample, long-term longitudinal study was conducted to explore the trends and characteristics of changes in growth, development in pediatric liver transplant recipients, with the aim of guiding the development of intervention strategies and optimizing follow-up protocols.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- Up to 1 year
- Sex
- All
- Age groups
- Child
- Study population
- Children who underwent liver transplantation.
Key inclusion criteria (3 listed)
- Children with end-stage liver disease of various etiologies requiring liver transplantation.
- Approved by the ethics committee, and written informed consent has been obtained from the parents/legal guardians.
- Age ≤ 1 year (infancy).
Key exclusion criteria (2 listed)
- Age older than 1 year old.
- Accept liver kidney combined transplantation surgery or second liver transplantation surgery.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
BMI Z-score
Time frame: 1 week before liver transplantation; 1 month, 3 months, 6 months, 1 year, 3 years, and 5 years after liver transplantation
1 secondary outcome
Overall survival
Time frame: 1 week before liver transplantation; 1 month, 3 months, 6 months, 1 year, 3 years, and 5 years after liver transplantation
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 May 2026.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Growth, Development in Pediatric Liver Transplant Recipients, run by RenJi Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
BMI Z-score (time frame: 1 week before liver transplantation; 1 month, 3 months, 6 months, 1 year, 3 years, and 5 years after liver transplantation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2026; AzTrials last refreshed its copy on 7 Nov 2026.